Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results
Date:3/11/2013

NEW YORK, March 11, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease (the "Company"), today announced its results for the fourth quarter and year ended December 31, 2012.

At December 31, 2012, the Company had cash, cash equivalents, interest receivable, and investment securities of $14.7 million, as compared to $39.5 million at December 31, 2011.  Subsequent to December 31, 2012, the Company completed an underwritten public offering of common stock, which provided proceeds to the Company of approximately $74.8 million, net of underwriting discounts and offering expenses of approximately $5.6 million.  Also subsequent to December 31, 2012, the Company received a $7.0 million milestone payment from its Japanese partner for Zerenex (ferric citrate), Japan Tobacco Inc. ("JT") and Torii Pharmaceutical Co., Ltd. ("Torii"), related to JT's January 2013 filing of a New Drug Application ("NDA") with the Japanese Ministry of Health, Labour and Welfare for marketing approval of ferric citrate in Japan for the treatment of hyperphosphatemia in patients with chronic kidney disease.

The net loss for the fourth quarter ended December 31, 2012 was $6.6 million, or $0.09 per share, compared to a net loss of $8.4 million, or $0.12 per share, for the comparable quarter in 2011, representing a decrease in net loss of $1.8 million.  The change in net loss in the fourth quarter of 2012, as compared to the fourth quarter of 2011, was primarily attributable to a $3.1 million decrease in research and development expenses due to the cessation of the development of KRX-0401 (perifosine) in May 2012, partially offset by a $1.3 million increase
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results
2. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
3. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Keryx Biopharmaceuticals Announces $55 Million Proposed Public Offering of Common Stock
5. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2012 Financial Results
6. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
8. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
9. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
10. Par Pharmaceutical Announces Quarterly Conference Call
11. HeartWare International, Inc. Announces Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Research and Markets has announced the addition ... report to their offering. Benefiting ... for medical expenses, the Chinese orthopedic instrument market demand ... CAGR of 19.2% during 2009-2013. Trauma products, spine products ... instruments in China , of which ...
(Date:8/29/2014)... 2014 According to a ... Extraction type (SFE, Cold Pressed, Organic Solvent, & Others), ... Food Supplements, Fragrance, & Others) - Global Trends & ... segments the Amaranth Seed Oil Market with an ... terms of value. The Amaranth Seed Oil Market ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2
... 3 Hanly Conroy Bierstein Sheridan Fisher ... the resolution of their client Synergetics USA, Inc.,s (Nasdaq: ... Alcon, Inc.  Synergetics announced on April 27, 2010 , ... and a Supply Agreement with Alcon, pursuant to which all ...
... , May 3 Rescue Riders, a national volunteer ... provide emergency medical assistance, has selected the HeartSine® samaritan® PAD Automated ... , , ... than 3,000 motorcycle-riding volunteers in 40 states who are trained as ...
Cached Medicine Technology:Hanly Conroy Announces Settlement of Contingent Fee Antitrust Lawsuit 2Hanly Conroy Announces Settlement of Contingent Fee Antitrust Lawsuit 3Motorcyclist Volunteers Come to the Rescue With HeartSine AEDs 2
(Date:8/29/2014)... Formed in 2014, KAJ Brothers is a ... years. Their sophisticated Pop/R&B sound, with beautiful orchestral elements ... enough to experience every day. , The band ... feeling loved with the primary purpose of elevating women with ... group unanimously replied - “To make chivalry cool again, and ...
(Date:8/29/2014)... August 29, 2014 Healthpointe is proud ... Rodas. Dr. Rodas will be practicing out of Healthpointe’s ... a member of Healthpointe’s orthopedic team, Dr. ... medicine, and board-certified in occupational medicine. , Among ... as Medical Director of Raytheon, the world-class defense and ...
(Date:8/29/2014)... Healthpointe has unveiled its new virtual ... convenience of visiting with physicians online. Anyone can sign ... Healthpointe doctors are always available and happy to see ... doctor can even see the patient’s entire family. Once ... she can prescribe medications that are available for pick-up ...
(Date:8/29/2014)... Dr. Parsa Mohebi M.D. has developed new techniques that ... results in hair transplantation. One of these techniques is ... method that harvests facial hair for transplanting to the patient’s ... hair loss classification is 5 and above achieve reasonable coverage ... for those advanced hair loss patients who may not have ...
(Date:8/29/2014)... 29, 2014 A recent article ... by a Tokyo clothing store for men with gynecomastia, or ... rectifying or diminishing their problem. Board-certified plastic surgeon Dr. Chasan ... problem. While many people only associate male breasts with men ... condition among men of all ages, often starting in adolescence. ...
Breaking Medicine News(10 mins):Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Dr. Anthony G. Rodas Joins Healthpointe Team at LAX Office 2Health News:Virtual Doctor’s Appointments Now Available at Healthpointe 2Health News:Advanced Hair Loss Patients Can Now Qualify for Hair Transplants Using Facial Donor Hair 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3
... ... coverage of anti-aging supplements has created a brand new market for health supplements, customers ... has garnered special attention, HGH Supplements like Sytropin. , ... (PRWEB) February 23, 2010 -- Increased positive coverage ...
... ... for training coders, admins, techs, and nurses through online continuing education. , ... Fort Lauderdale, FL (PRWEB) February ... has developed online continuing education programs for nurses , human resources administrators, and ...
... , ... ... ... ...
... ... ... ... ...
... February 23, 2010 Researchers from The George Washington University, ... that asthma, a largely manageable and chronic disease, is on ... magnitude of the asthma crisis, the surging cost of treatment, ... are uninsured. A new report from GW, Changing pO2licy: ...
... condition that leads to severe physical and mental deterioration, psychiatric ... to slow down or stop it. HD sufferers are ... until late in life. In a new study published ... Fabiola Ribeiro of Robarts Research Institute at The University of ...
Cached Medicine News:Health News:Sytropin HGH Shows Promising Anti-Aging Results 2Health News:Kaplan Continuing Education Expands Health Care Certificate Programs 2Health News:Kaplan Continuing Education Expands Health Care Certificate Programs 3Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 2Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 3Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 4Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 5Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 2Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 3Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 4Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 5Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 6Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 7Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 8Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 9Health News:Startling new childhood asthma data 2Health News:Startling new childhood asthma data 3Health News:Startling new childhood asthma data 4Health News:Protecting the brain from of a deadly genetic disease 2
The Embla 96/384 well washer is a top-loading, robotic-compatible plate washer for 96- and 384-well microplate washing. It is ideal for ELISAs and most cell applications....
Auto Plate Washer: 96-well washing. The ELx405 Auto Washer is the most precise and reliable washer available. Many unique features lower background absorbance values and increase the signal-to-noise ...
... This new microplate reader for fluorescence ... an emphasis on superior performance in ... sensitive glow luminescence measurements. Synergy HT ... mm top, 5 mm bottom probe, ...
EL301 Microwell Strip Reader is a portable, rugged, single/dual wavelength photometer designed to measure and interpret the absorbances of microwell strip assays....
Medicine Products: